Invasive coronary angiography (ICA) has long been the established gold standard in assessing graft patency following coronary artery bypass graft (CABG). Over the past decade or so however, improvements in computed tomography angiography (CTA) technology have allowed its emergence as a useful clinical tool in graft assessment. The recent introduction of 64-slice and now 128-slice scanners into widespread distribution, and the development of 320-detector row technology allowing volumetric imaging of the entire heart at single points in time within one cardiac cycle, has increased the potential of CTA to supersede ICA in this capacity. This study sought to examine the evidence surrounding this potential. A best evidence topic was constructed according to a structured protocol. The enquiry: In [ patients who have undergone coronary artery bypass graft surgery] is [computed tomography angiography or invasive coronary angiography] superior in terms of [graft patency assessment, stenosis detection, radiation exposure and complication rate]? Four hundred and twenty-four articles were identified from the search strategy. Four additional articles were identified from references of key articles. Seventeen articles selected as best evidence were tabulated. The reliability of CTA as a tool in the detection of graft patency and stenosis has continued to improve with each successive generation of multislice technology. The latest 64-and 128-slice CTA techniques are able to detect graft patency and stenosis with very high sensitivities and specificities comparable with ICA, while remaining non-invasive procedures associated with fewer complications (ICA carries a 0.08% risk of myocardial infarction and 0.7% risk of minor complications in clinically stable patients). Present limitations of the technology include the accurate visualization of distal anastomoses and clip artefacts. In addition, the capacity of diagnostic ICA to be combined simultaneously with percutaneous coronary interventions is an important advantage and a further limitation of CTA alone. Recent developments, however, including the derivation of fractional flow reserve and perfusion assessment from CTA as functional measures of stenosis severity have given CTA at present the capacity to become a first-line tool in the assessment of patients with suspected graft dysfunction. Novel computer-automated diagnostic software, though currently in infancy, has shown promise in facilitating and speeding image interpretation. With further improvements in scanning technologies, CTA is likely to supersede ICA for graft assessment in the near future.
INTRODUCTION
A best evidence topic was conducted according to the structured protocol described in ICVTS [1] .
SEARCH STRATEGY
A search of MEDLINE, CINAHL and EMBASE databases from 1950 to September 2014 was performed: ((CT angiography) AND (CABG OR graft patency)).ti,ab. Searches were repeated and verified by Stefan Klimach and any disagreements resolved by Peter Lang. Reference lists of key articles were analysed to identify further articles.
SEARCH OUTCOME
Four hundred and twenty-four articles were identified from the search strategy. Four additional articles were identified from references of key articles.
Seventeen articles were selected as best evidence. These are presented in Table 1 .
RESULTS
Hamon et al.'s [1] well-constructed and high-powered metaanalysis of 15 pooled studies, encompassing 723 patients with 2023 grafts demonstrated that obstructive bypass disease can be detected with both 16-and 64-slice CTA with a high diagnostic accuracy (90 and 96%, respectively, P < 0.001), overall sensitivity (97.6%, 95% CI: 96-98.6%) and specificity (96.7%, 95% CI: 95.6-97.5%), with detection of graft occlusion superior to that of substantial stenosis. The authors noted, however, that 7.6% of all grafts were not fully assessable, and that some studies lacked a complete acquisition of the grafts, meaning relevant stenoses of segments may have remained undetected.
Goetti et al.'s [2] prospective cohort study sought to assess 128-slice CTA in high-pitch spiral acquisition mode for evaluation of graft patency regarding imaging quality and radiation dose. Only 3/465 (0.6%) of segments (all distal anastomoses) were of non-diagnostic image quality. The authors concluded that patency of the grafts could be assessed with decreasing image quality at high resolution by the high-pitch 128-slice technology. They also noted that high-pitch acquisition mode was associated with a remarkably low radiation exposure (2.3 ± 0.3 mSv), more than 8-fold lower than that of conventional helical 64-slice CTA. Limitations of this study include the lack of direct comparison with ICA to look at accuracy, which also limited the study to the determination of patency and not stenosis of grafts.
Meyer et al.'s [3] prospective cohort study evaluated graft patency, using 64-slice CTA followed by ICA in 131 patients with a total of 418 grafts. Overall, 98% of grafts were evaluable with 97% sensitivity, 97% specificity, 93% positive predictive value (PPV) and 99% negative predictive value (NPV). Thirty percent of patients had arrhythmias. Evaluability of grafts in patients with arrhythmias was decreased (100 vs 95%, P < 0.01). Sensitivity, specificity, PPV and NPV were all similar. The report also assessed radiation exposure, which was significantly higher for CTA (17.8 ± 5.4 vs 8.8 ± 4.5 mSv, P < 0.05), and volume of contrast agent required, which was significantly lower for CTA (148 ± 22 vs 223 ± 99 ml, P < 0.05). The study appeared methodologically sound and supported the use of CTA in the presence of arrhythmia.
Jabara et al.'s [4] prospective cohort study evaluated graft patency in 50 patients with 147 grafts using 64-slice CTA followed by ICA. Overall, 98.6% of grafts were evaluable, with 93.3% sensitivity, 100% specificity, 100% PPV and 98.3% NPV for occluded grafts, with 100% in all metrics for significant stenoses. One patient suffered a serious complication of ICA (retroperitoneal haematoma) in contrast to no complications with CTA. Radiation exposure was significantly higher for CTA (44.7 ± 14.4 vs 7.2 ± 4.4 mSv, P < 0.001) but contrast medium required was significantly lower for CTA (130 ± 48 vs 110 ± 10 ml, P = 0.002) as was procedure time (44.7 ± 14.4 vs 7.2 ± 4.4 min, P < 0.001). Overall, this methodologically sound study demonstrated fewer complications and shorter procedure time for CTA, at the expense of greater radiation exposure.
Monem et al. [5] and Weustink et al. [6] both performed prospective cohort studies, evaluating a total of 82 patients with 166 grafts using 64-slice CTA. Reported diagnostic accuracy was 97.4% in the former, with 100% sensitivity and 97.1-100% specificity. Limitations of the technique included clip artefacts and requisite beta-blockade to enhance image quality.
Anders et al. [7] , Yoo et al. [8] , Schlosser et al. [9] , Malhotra et al. [10, 11] , Turkvatan et al. [12] and Houslay et al. [13] , performed prospective cohort studies evaluating a total of 457 patients with 1259 grafts using 16-slice CTA. Although protocols varied slightly between studies, overall graft evaluability was 90-99.3%, with 69-100% sensitivity, 91-100% specificity, 53-100% PPV and 94.8-100% NPV. The majority of these studies concluded in favour of CTA.
CLINICAL BOTTOM LINE
The reliability of CTA as a tool in the detection of graft patency and stenosis has continued to improve with each successive generation of multislice technology. The latest 64-and 128-slice CTA techniques are able to detect graft patency and stenosis with very high sensitivities and specificities comparable with ICA while remaining non-invasive procedures associated with fewer complications (ICA carries a 0.08% risk of myocardial infarction and 0.7% risk of minor complications in clinically stable post-CABG patients [18] ). However, present significant limitations of the technology include the accurate visualization of distal anastomoses and clip artefacts. Additionally, CTA suffers the same limitation as ICA with regard to the identification of the functional consequences of stenosis: not every anatomical stenosis of graft tissue will result in ischaemia requiring intervention. In this regard therefore, the capacity of ICA to be simultaneously combined with percutaneous coronary intervention if judged necessary is an important advantage over CTA and a major limitation of the technique. One limitation of our paper is the presentation of studies using 16-slice technology, which has now been largely superseded by 64-and 128-slice CTA.
Recent developments, however, including the derivation of fractional flow reserve [19] and perfusion assessment from CTA as functional measures of stenosis severity have given CTA at present the capacity to become a first-line tool in the assessment of patients with suspected graft dysfunction. Novel computer-automated diagnostic software, though currently in infancy, has shown promise in facilitating and speeding image interpretation [20] . With further improvements in scanning technologies, CTA is likely to supersede ICA for graft assessment in the near future. The authors noted that 7.6% of grafts were not fully assessable, and that some studies did not perform a complete acquisition of the grafts (origin and proximal part of the internal mammary artery grafts were not covered by scan volume), meaning relevant stenosis of the segment may not have been detected This study drew particular attention to the distal run-off and also evaluated non-grafted vessels. The diagnostic performance remained relatively high for these although performed less well than for evaluation of the grafts, perhaps due to the increased motion 
